Use of omega-3-fatty acids in the treatment of diabetic patients

Details for Australian Patent Application No. 2004216856 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Verboom, Cees-Nico; Oelze, Rainer

Agent Watermark

Pub. Number AU-A-2004216856

PCT Pub. Number WO2004/078166

Priority 03004792.2 05.03.03 EP

Filing date 2 March 2004

Wipo publication date 16 September 2004

International Classifications

A61K 031/00

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/078166 Priority application(s): WO2004/078166

15 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216857-G-lactam derivatives as prostaglandin agonists

2004216853-Low irritation lathering formulations